華聯股份(000882.SZ):部分董事、高管增持合計71.86萬股
格隆匯6月13日丨華聯股份(000882.SZ)公佈,2024年6月13日,北京華聯商廈股份有限公司分別收到董事長、總經理王鋭先生,董事馬作羣先生,董事、副總經理、董事會祕書周劍軍先生,董事、財務總監王欣榮女士通知,基於對公司長期投資的價值和未來發展前景的認可,支持公司持續、穩定發展,上述人員於2024年6月12日、2024年6月13日通過深圳證券交易所集中競價交易系統增持了公司股份,本次增持股份數量合計71.86萬股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.